Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Russo

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Current Pharmaceutical Design|March 20, 2014
P4 medicine needs P4 educationAlfredo Cesario, Charles Auffray, Patrizia Russo, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|March 23, 2004
Farnesylated proteins as anticancer drug targets: from laboratory to the clinicPatrizia Russo, Maura Loprevite, Alfredo Cesario, et al.
Drug Discovery Today|July 21, 2009
alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?Laura Paleari, Alfredo Cesario, Massimo Fini, et al.
Seminars in Cancer Biology|February 12, 2008
The cholinergic system and cancerLaura Paleari, Alessia Grozio, Alfredo Cesario, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitorPatrizia Russo, Dario Arzani, Sonya Trombino, et al.
International Journal of Cancer|February 22, 2002
Human papillomavirus type 16 E6-enhanced susceptibility to apoptosis induced by TNF in A2780 human ovarian cancer cell lineFaina Vikhanskaya, Carla Falugi, Piera Valente, et al.
Life Sciences|June 19, 2012
Nicotinic receptor and tobacco-related cancerPatrizia Russo, Alessio Cardinale, Stefano Margaritora, et al.
Current Medicinal Chemistry|May 15, 2018
Flavonoids and Reduction of Cardiovascular Disease (CVD) in Chronic Obstructive Pulmonary Disease (COPD)Patrizia Russo, Giulia Prinzi, Palma Lamonaca, et al.
Current Drug Targets|October 2, 2015
Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's DiseasePatrizia Russo, Aliaksei Kisialiou, Rossana Moroni, et al.
Current Cancer Drug Targets|April 8, 2003
Increasing complexity of farnesyltransferase inhibitors activity: role in chromosome instabilityCarla Falugi, Sonya Trombino, Pierluigi Granone, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Current Pharmaceutical Design|March 20, 2014
P4 medicine needs P4 educationAlfredo Cesario, Charles Auffray, Patrizia Russo, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|March 23, 2004
Farnesylated proteins as anticancer drug targets: from laboratory to the clinicPatrizia Russo, Maura Loprevite, Alfredo Cesario, et al.
Drug Discovery Today|July 21, 2009
alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?Laura Paleari, Alfredo Cesario, Massimo Fini, et al.
Seminars in Cancer Biology|February 12, 2008
The cholinergic system and cancerLaura Paleari, Alessia Grozio, Alfredo Cesario, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitorPatrizia Russo, Dario Arzani, Sonya Trombino, et al.
International Journal of Cancer|February 22, 2002
Human papillomavirus type 16 E6-enhanced susceptibility to apoptosis induced by TNF in A2780 human ovarian cancer cell lineFaina Vikhanskaya, Carla Falugi, Piera Valente, et al.
Life Sciences|June 19, 2012
Nicotinic receptor and tobacco-related cancerPatrizia Russo, Alessio Cardinale, Stefano Margaritora, et al.
Current Medicinal Chemistry|May 15, 2018
Flavonoids and Reduction of Cardiovascular Disease (CVD) in Chronic Obstructive Pulmonary Disease (COPD)Patrizia Russo, Giulia Prinzi, Palma Lamonaca, et al.
Current Drug Targets|October 2, 2015
Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's DiseasePatrizia Russo, Aliaksei Kisialiou, Rossana Moroni, et al.
Current Cancer Drug Targets|April 8, 2003
Increasing complexity of farnesyltransferase inhibitors activity: role in chromosome instabilityCarla Falugi, Sonya Trombino, Pierluigi Granone, et al.
Pageof 10